HRMY
Harmony Biosciences Holdings
41.20$
+1.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | +46.6% | +51.9% | +0.2% | +58.4% | |
| – | +1,966.3% | +169.3% | +105.9% | +18.8% | -2.8% | -1.0% | +5.1% | |
| – | +818.4% | -52.6% | +243.2% | +67.1% | +17.8% | +34.4% | +5.4% | |
| – | +5,872.8% | -48.9% | +28.3% | -237.9% | – | – | – | |
| – | – | -442.6% | – | -415.2% | – | -120.9% | – | |
| – | -88.9% | +1,243.6% | -85.1% | -42.3% | +81.4% | +269.6% | -73.1% | |
| – | +9,374.6% | -98.4% | +4,909.9% | +41.4% | -67.3% | +45.3% | -41.2% | |
| – | – | +39.3% | – | – | – | – | – | |
| – | -64.6% | -85.2% | – | -77.4% | -1,231.1% | -100.0% | – | |
| – | +0.0% | -2.5% | -100.5% | +300.0% | -37.5% | +1,100.0% | +8.3% | |
| – | +565.1% | +45.5% | -96.5% | -7.8% | -1,642.9% | -89.6% | -17.7% | |
| – | – | – | -97.2% | +66.9% | +611.3% | +109.7% | +111.9% | |
| – | – | – | – | +46.9% | +51.8% | -0.2% | +59.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.